The global kasugamycin market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing demand for kasugamycin in various applications such as vegetables, melons and fruits, rice and corns. Kasugamycin is used as an antibiotic in agriculture for controlling bacterial diseases that affect crops such as rice and corns. Kasugamycin has been found to be effective against bacteria like Xanthomonas oryzae pv oryzae (Xoo), Pseudomonas syringae pv tomato (Pst) and Erwinia amylovora (Ea). These bacteria are responsible for causing diseases like bacterial leaf blight, bacterial wilt of banana plants, fire blight of pear trees and apple scab respectively.
Kasugamycin 2%, Kasugamycin 4%, Kasugamycin 6% are the types of kasugamycins available in the global market which are used in different applications such as vegetables, melons and fruits, rice and corns respectively. The application segment is expected to dominate the global kasugamycins market with a share of over 60%. This can be attributed to its wide usage across various industries including agriculture where it is used for controlling bacterial diseases that affect crops such as rice and corns.
Some Of The Growth Factors Of This Market:
- Kasugamycin is a potent antibiotic that is used to treat bacterial infections in humans and animals.
- Kasugamycin has been approved for use in the United States since 1978, and it is also approved for use in Europe, Canada, Australia, and Japan.
- The drug has been shown to be effective against a wide range of bacteria including: Streptococcus pneumoniae (pneumonia), Haemophilus influenzae (ear infection), Staphylococcus aureus (skin infection), Escherichia coli (diarrhea).
- Kasugamycin can be administered intravenously or orally depending on the severity of the infection.
- The drug's efficacy against certain bacteria makes it an attractive treatment option for patients with multi-drug resistant strains.
Industry Growth Insights published a new data on “Kasugamycin Market”. The research report is titled “Kasugamycin Market research by Types (Kasugamycin 2%, Kasugamycin 4%, Kasugamycin 6%, Other), By Applications (Vegetables, Melons and Fruits, Rice and Corns, Other), By Players/Companies Hegno, Hubei Saichuang, King Quenson, Zhejiang Rayfull Chemicals, SHALI CHEM & ART, Changzhou SYNchem, Hokko Chemical, Fenchem, Arysta Lifesciences, Anhui Royal Chemical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Kasugamycin Market Research Report
By Type
Kasugamycin 2%, Kasugamycin 4%, Kasugamycin 6%, Other
By Application
Vegetables, Melons and Fruits, Rice and Corns, Other
By Companies
Hegno, Hubei Saichuang, King Quenson, Zhejiang Rayfull Chemicals, SHALI CHEM & ART, Changzhou SYNchem, Hokko Chemical, Fenchem, Arysta Lifesciences, Anhui Royal Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Kasugamycin Market Report Segments:
The global Kasugamycin market is segmented on the basis of:
Types
Kasugamycin 2%, Kasugamycin 4%, Kasugamycin 6%, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Vegetables, Melons and Fruits, Rice and Corns, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hegno
- Hubei Saichuang
- King Quenson
- Zhejiang Rayfull Chemicals
- SHALI CHEM & ART
- Changzhou SYNchem
- Hokko Chemical
- Fenchem
- Arysta Lifesciences
- Anhui Royal Chemical
Highlights of The Kasugamycin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Kasugamycin 2%
- Kasugamycin 4%
- Kasugamycin 6%
- Other
- By Application:
- Vegetables
- Melons and Fruits
- Rice and Corns
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Kasugamycin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Kasugamycin is a type of antibiotic that is used to treat infections caused by bacteria. It works by killing the bacteria cells. Kasugamycin is usually taken by mouth, but it can also be given as an injection into a vein.
Some of the major players in the kasugamycin market are Hegno, Hubei Saichuang, King Quenson, Zhejiang Rayfull Chemicals, SHALI CHEM & ART, Changzhou SYNchem, Hokko Chemical, Fenchem, Arysta Lifesciences, Anhui Royal Chemical.
The kasugamycin market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Kasugamycin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Kasugamycin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Kasugamycin Market - Supply Chain
4.5. Global Kasugamycin Market Forecast
4.5.1. Kasugamycin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Kasugamycin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Kasugamycin Market Absolute $ Opportunity
5. Global Kasugamycin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Kasugamycin Market Size and Volume Forecast by Type
5.3.1. Kasugamycin 2%
5.3.2. Kasugamycin 4%
5.3.3. Kasugamycin 6%
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Kasugamycin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Kasugamycin Market Size and Volume Forecast by Application
6.3.1. Vegetables
6.3.2. Melons and Fruits
6.3.3. Rice and Corns
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Kasugamycin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Kasugamycin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Kasugamycin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Kasugamycin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Kasugamycin Demand Share Forecast, 2019-2026
9. North America Kasugamycin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Kasugamycin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Kasugamycin Market Size and Volume Forecast by Application
9.4.1. Vegetables
9.4.2. Melons and Fruits
9.4.3. Rice and Corns
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Kasugamycin Market Size and Volume Forecast by Type
9.7.1. Kasugamycin 2%
9.7.2. Kasugamycin 4%
9.7.3. Kasugamycin 6%
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Kasugamycin Demand Share Forecast, 2019-2026
10. Latin America Kasugamycin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Kasugamycin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Kasugamycin Market Size and Volume Forecast by Application
10.4.1. Vegetables
10.4.2. Melons and Fruits
10.4.3. Rice and Corns
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Kasugamycin Market Size and Volume Forecast by Type
10.7.1. Kasugamycin 2%
10.7.2. Kasugamycin 4%
10.7.3. Kasugamycin 6%
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Kasugamycin Demand Share Forecast, 2019-2026
11. Europe Kasugamycin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Kasugamycin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Kasugamycin Market Size and Volume Forecast by Application
11.4.1. Vegetables
11.4.2. Melons and Fruits
11.4.3. Rice and Corns
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Kasugamycin Market Size and Volume Forecast by Type
11.7.1. Kasugamycin 2%
11.7.2. Kasugamycin 4%
11.7.3. Kasugamycin 6%
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractivness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Kasugamycin Demand Share, 2019-2026
12. Asia Pacific Kasugamycin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Kasugamycin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Kasugamycin Market Size and Volume Forecast by Application
12.4.1. Vegetables
12.4.2. Melons and Fruits
12.4.3. Rice and Corns
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Kasugamycin Market Size and Volume Forecast by Type
12.7.1. Kasugamycin 2%
12.7.2. Kasugamycin 4%
12.7.3. Kasugamycin 6%
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Kasugamycin Demand Share, 2019-2026
13. Middle East & Africa Kasugamycin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Kasugamycin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Kasugamycin Market Size and Volume Forecast by Application
13.4.1. Vegetables
13.4.2. Melons and Fruits
13.4.3. Rice and Corns
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Kasugamycin Market Size and Volume Forecast by Type
13.7.1. Kasugamycin 2%
13.7.2. Kasugamycin 4%
13.7.3. Kasugamycin 6%
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Kasugamycin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Kasugamycin Market: Market Share Analysis
14.2. Kasugamycin Distributors and Customers
14.3. Kasugamycin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Hegno
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Hubei Saichuang
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. King Quenson
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Zhejiang Rayfull Chemicals
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. SHALI CHEM & ART
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Changzhou SYNchem
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Hokko Chemical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Fenchem
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Arysta Lifesciences
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Anhui Royal Chemical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
